Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on International Tech Times.
Press releases published on March 20, 2025
Abeona Therapeutics® Reports Full Year 2024 Financial Results, Provides Pz-cel Regulatory Update and Commercial Launch Plans
GlobeNewswire
·
March 20, 2025
FDA priority review of pz-cel Biologics License Application (BLA) progressing with Prescription Drug User Fee Act (PDUFA) target action date of April 29, 2025 Launch preparations on track toward goal to treat first patient in 3Q 2025 CLEVELAND, March 20, …
Cytokinetics Announces Launch of EARTH-HCM, a Public Health Education Tool for the Hypertrophic Cardiomyopathy Community
GlobeNewswire
·
March 20, 2025
Interactive Tool Harnesses Real-World Data to Visualize Burden of Disease in HCM and Advance Equitable Access to Care SOUTH SAN FRANCISCO, Calif., March 20, 2025 (GLOBE NEWSWIRE) -- Cytokinetics, Incorporated (Nasdaq: CYTK) today announced the launch of …
3 E Network Technology Group Limited Announces Strategic Equity Investment in HashBeaver to Accelerate Blockchain Innovation
GlobeNewswire
·
March 20, 2025
Partnership Combines the Company’s B2B IT Expertise with HashBeaver’s Cutting-Edge Cloud Mining Solutions for Cross-Industry Growth Guangzhou, China, March 20, 2025 (GLOBE NEWSWIRE) -- 3 E Network Technology Group Limited (“3e Network” or the “Company”) ( …
InflaRx Reports Full Year 2024 Results and Highlights Key Achievements and Expected Milestones
GlobeNewswire
·
March 20, 2025
Received European Commission approval for GOHIBIC® (vilobelimab) for the treatment of SARS-CoV-2-induced acute respiratory distress syndrome (ARDS) Achieved 30-patient recruitment milestone in Phase 3 vilobelimab trial in pyoderma gangrenosum (PG) to …
Barinthus Bio Reports Full Year 2024 Financial Results and Updates on Corporate Developments
GlobeNewswire
·
March 20, 2025
Strategic transformation ongoing, positioning the Company as a focused leader in immunology and inflammatory diseases Highly differentiated, potentially curative immunotherapy for celiac disease (VTP-1000) in the clinic, with first data expected in third …
Arras Minerals Announces Up to $15 Million Financing
GlobeNewswire
·
March 20, 2025
NOT FOR DISTRIBUTION TO UNITED STATES NEWS WIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES VANCOUVER, British Columbia, March 20, 2025 (GLOBE NEWSWIRE) -- Arras Minerals Corp. (TSX-V: ARK, OTCQB: ARRKF) (“Arras” or the “Company”) is pleased to …
Chris Miller, Former Acting U.S. Secretary of Defense Appointed by President Trump, Joins the Draganfly Board of Directors
GlobeNewswire
·
March 20, 2025
Tampa, Florida, March 20, 2025 (GLOBE NEWSWIRE) -- Draganfly Inc, (NASDAQ: DPRO) (CSE: DPRO) (FSE: 3U8A) (“Draganfly” or the “Company”), an award-winning, industry-leading drone solutions and systems developer, is proud to announce that Christopher C. …
Emerging Markets Report: Ceilings & Floors
GlobeNewswire
·
March 20, 2025
An Emerging Markets Sponsored Commentary ORLANDO, Fla., March 20, 2025 (GLOBE NEWSWIRE) -- At the Emerging Market Report we are definitively newshounds, constantly looking to see what news from a Company could further its fortunes or more rarely, what news …
Clearside Biomedical’s Lead Clinical Program CLS-AX in Wet AMD and Suprachoroidal Delivery Platform Highlighted at the 2025 Wet AMD & Diabetic Eye Disease Summit
GlobeNewswire
·
March 20, 2025
- Post-Hoc Analyses Provide Comparative Data on Rescue Criteria and Intervention- Free Rates for Tyrosine Kinase Inhibitors (TKIs) in Wet AMD Development - - Unique Ability to Re-Dose CLS-AX vs Rescue Supports Regulatory …
Robotic Process Automation Market Skyrockets to $20.82 Billion by 2031 Dominated by Tech Giants – Appian Corp, Automation Anywhere, Blue Prism and Cyclone Robotics | The Insight Partners
GlobeNewswire
·
March 20, 2025
US …
Cognition Therapeutics Reports Year End 2024 Financial Results and Provides Business Update
GlobeNewswire
·
March 20, 2025
Positive Results with Zervimesine (CT1812) in Phase 2 SHIMMER Dementia with Lewy Bodies (DLB) Phase 2 SHINE Data Show Dramatic Slowing of Cognitive Decline with Zervimesine in a Key Pre-specified Alzheimer’s Disease Subgroup 2025 Objective: Advance …
Amphista Therapeutics to present novel mechanism of action for the degradation of BRD9 using its proprietary Targeted Glue® technology at two key upcoming scientific conferences
GlobeNewswire
·
March 20, 2025
Amphista Therapeutics to present novel mechanism of action for the degradation of BRD9 using its proprietary Targeted Glue® technology at two key upcoming scientific conferences Oral presentations will detail the rapid, deep and persistent degradation of …
FPO/TPO Synthetic Roofing Membrane Market is Projected USD 1,489.0 Million, Expanding at 4.4% CAGR by 2035 | Fact.MR Analysis
GlobeNewswire
·
March 20, 2025
Rockville, MD, March 20, 2025 (GLOBE NEWSWIRE) -- According to Fact.MR, a market research and competitive intelligence provider, the FPO/TPO synthetic roofing membrane market was valued at USD 928.3 million in 2024 and is expected to grow at a CAGR of 4.4% …
Axonius Unveils the Axonius Asset Cloud, a Suite of Products that Transforms Asset Intelligence into Intelligent Action
GlobeNewswire
·
March 20, 2025
DALLAS, March 20, 2025 (GLOBE NEWSWIRE) -- Axonius, the leader in cyber asset management that delivers visibility and actionability across all digital assets, today introduced the Axonius Asset Cloud, a groundbreaking suite of products designed to …
Wugen Announces Dosing of First Patients in Pivotal Trial of Off-the-Shelf, Allogeneic, CD7-Targeted CAR-T Cell Therapy WU-CART-007
GlobeNewswire
·
March 20, 2025
-- Previously reported Phase 1/2 data on WU-CART-007 demonstrated clinically manageable safety and evidence of anti-leukemic activity with an overall response rate of 91% and composite complete remission rate of 73% in heavily pretreated patients with R/R …
Intermap’s Insurance Business Starts 2025 With Strong Growth
GlobeNewswire
·
March 20, 2025
Year-to-date insurance awards surpass $1.1 million Two new strategic partnerships with major insurance customers DENVER, March 20, 2025 (GLOBE NEWSWIRE) -- Intermap Technologies (TSX: IMP; OTCQB: ITMSF) (“Intermap” or the “Company”), a global leader in 3D …
Avalo Reports 2024 Financial Results and Recent Business Updates
GlobeNewswire
·
March 20, 2025
Topline data from Phase 2 LOTUS Trial of AVTX-009 for the treatment of hidradenitis suppurativa expected in 2026 Appointed Jennifer Riley as Chief Strategy Officer Cash on hand of approximately $135 million as of December 31, 2024 expected to provide …
Eyenovia Enters into Non-Binding Letter of Intent to Effect Reverse Merger with Betaliq
GlobeNewswire
·
March 20, 2025
Combination, if successful, would create a new publicly-listed eye care company combining Betaliq’s EyeSol® water-free drug delivery technology for glaucoma with Eyenovia’s Optejet® device platform The combined company would continue marketing Eyenovia’s …
Predictive Oncology Completes Sale of Skyline Medical Assets to DeRoyal Industries
GlobeNewswire
·
March 20, 2025
Deal positions STREAMWAY® Systems with an established market leader to drive accelerating growth Transaction allows Predictive Oncology to be highly focused on its core AI-driven drug discovery capabilities and integrate seamlessly with Renovaro …
Sionna Therapeutics Reports Fourth Quarter and Full Year 2024 Financial Results
GlobeNewswire
·
March 20, 2025
Phase 1 MAD dosing completed for SION-451 and final MAD cohort of SION-719 planned; Interim data in healthy volunteers show potential to provide clinically meaningful benefit to CF patients. Topline data anticipated in first half of 2025 On track to …